+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • December 2023
  • 182 Pages
  • Global
From
From
From
From
From
From
From
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
Respiratory Syncytial Virus Infections - Pipeline Insight, 2021 - Product Thumbnail Image

Respiratory Syncytial Virus Infections - Pipeline Insight, 2021

  • Clinical Trials
  • June 2021
  • 60 Pages
  • Global
From
Immunoglobulins Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
Loading Indicator